UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
ENHANCE SKIN PRODUCTS, INC.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
29332N 107
(CUSIP Number)
Crisnic Fund, S.A.
c/o Lexperts, S.A.
Conhotel Office, Center Office 5
Sabana Norte
San Jose, Costa Rica 224-1007
011-506-8702991
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications
November 4, 2010
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), (f) or (g), check the following box. [ ]
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13D
-------------------- -----------------
CUSIP NO. 29332N 107 Page 2 of 5 Pages
-------------------- -----------------
1 NAMES OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Crisnic Fund, S.A.
--------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [X]
--------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
--------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------
6 CITZENSHIP OR PLACE OF ORGANIZATION
Costa Rica
--------------------------------------------------------------------------
7 SOLE VOTING POWER
4,000,000 shares of Common Stock
NUMBER OF ---------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 4,000,000 shares of Common Stock
PERSON ---------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
-0-
---------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,000,000 shares of Common Stock
--------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]
--------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.51% of Common Stock
--------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------
SCHEDULE 13D
-------------------- -----------------
CUSIP NO. 29332N 107 Page 3 of 5 Pages
-------------------- -----------------
ITEM 1. SECURITY AND ISSUER
This statement relates to the Common Stock of Enhance Skin Products, Inc., a
Nevada corporation ("Issuer"). The address of Issuer's principal office is 695
South Colorado Boulevard, Suite 400, Denver, Colorado 80246.
ITEM 2. IDENTITY AND BACKGROUND
(a) Name
Crisnic Fund, S.A.
(b) Business Address
c/o Lexperts, S.A.
Conhotel Office, Center Office 5
Sabana Norte
San Jose, Costa Rica 224-1007
(c) Present Principal Occupation
Crisnic Fund, S.A. is in the business of buying and selling securities
for its own account.
(d) During the last five years, neither Crisnic Fund, S.A. nor Anthony
Gentile, President of Crisnic Fund, S.A., has been convicted in a
criminal proceeding (excluding traffic violations or similar
misdemeanors).
(e) During the last five years, neither Crisnic Fund, S.A. nor Anthony
Gentile, its President, has been a party to a civil proceeding of a
judicial or administrative body of competent jurisdiction as a result
of which either of them was or is subject to a judgment, decree or
final order enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state securities laws or
finding any violation with respect to such laws.
(f) Citizenship
Costa Rica.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
On August 3, 2010, the Issuer and Crisnic Fund, S.A. entered into an Indirect
Primary Offering Agreement ("IPOA") in order for Crisnic Fund, S.A. to provide
an "equity drawdown facility" for the Issuer. Pursuant to the IPOA, the Issuer
issued 1,750,000 shares of Common Stock to Crisnic Fund, S.A. as a fee valued at
an aggregate of $70,000 or $.04 per share.
On August 3, 2010, Crisnic Fund, S.A. purchased 750,000 shares of Common Stock
from the Issuer at $.04 per share or an aggregate of $30,000.
On November 4, 2010, Crisnic Fund, S.A. purchased 1,500,000 shares of Common
Stock from the Issuer at $.02 per share or an aggregate of $30,000.
SCHEDULE 13D
-------------------- -----------------
CUSIP NO. 29332N 107 Page 4 of 5 Pages
-------------------- -----------------
ITEM 4. PURPOSE OF TRANSACTION
All of shares described in Item 3, above, were acquired and/or purchased for
investment purposes by Crisnic Fund, S.A. Crisnic Fund, S.A. currently has no
plans or proposals that relate to or would result in:
(a) The acquisition by any person of additional securities of Issuer or
the disposition of securities of Issuer;
(b) An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving Issuer or any of its
subsidiaries;
(c) A sale or transfer of a material amount of assets of Issuer or any of
its subsidiaries;
(d) Any change in the present board of directors or management of Issuer,
including any plans or proposals to change the number or term of
directors or to fill any existing vacancies on the board;
(e) Any material change in the present capitalization or dividend policy
of Issuer;
(f) Any other material change in Issuer's business or corporate structure;
(g) Changes in Issuer's charter, bylaws or instruments corresponding
thereto or other actions which may impede the acquisition of control
of Issuer by any person;
(h) Causing a class of securities of Issuer to be delisted from a national
securities exchange or to cease to be authorized to be quoted in an
inter-dealer quotation system of a registered national securities
association;
(i) A class of equity securities of Issuer becoming eligible for
termination of registration pursuant to Section 12(g)(4) of the Act;
or
(j) Any action similar to any of those enumerated above.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) Aggregate Number and Percentage of Securities
According to the most recently available information, there are
approximately 53,250,000 shares of Issuer's Common Stock outstanding.
Crisnic Fund, S.A. beneficially owns 4,000,000 shares of Issuer's
Common Stock or approximately 7.51% of Issuer's issued and outstanding
Common Stock.
SCHEDULE 13D
-------------------- -----------------
CUSIP NO. 29332N 107 Page 5 of 5 Pages
-------------------- -----------------
(b) Power to Vote and Dispose
Anthony Gentile, President of Crisnic Fund, S.A., has sole power to
vote, or to direct the voting of, and the sole power to dispose or to
direct the disposition of the 4,000,000 shares of the Issuer's Common
Stock owned directly by Crisnic Fund, S.A.
(c) Transactions within the Past 60 Days
Neither Mr. Gentile nor Crisnic Fund, S.A. has engaged in any
transactions in Common Stock of Issuer during the past sixty days.
(d) Certain Rights of Other Persons
Not applicable.
(e) Date Reporting Person Ceased to be the Beneficial Owner of More Than
Five Percent of the class of securities, if applicable
Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER
Not applicable.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Not applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
February 25, 2013
--------------------------------------
(Date)
/s/ Anthony Gentile
--------------------------------------
Signature
Anthony Gentile, President
--------------------------------------
Name